Elasmogen, which is part of the Deepbridge Life Sciences EIS portfolio, are to collaborate with the University of Aberdeen as partner on a Scottish research award to assist with critical research to tackle the COVID-19 pandemic.
Caroline Barelle, CEO of Elasmogen commented;
“The Elasmogen team are delighted to be given the opportunity to deploy our soloMER technology platform..and are proud to be contributing to the global life sciences effort tackling this pandemic by working together with colleagues in Universities and other companies”.
- May 2021 (5)
- April 2021 (8)
- March 2021 (5)
- February 2021 (5)
- January 2021 (4)
- December 2020 (1)
- November 2020 (4)
- October 2020 (6)
- September 2020 (5)
- August 2020 (5)
- July 2020 (3)
- June 2020 (5)
- May 2020 (6)
- April 2020 (1)
- March 2020 (11)
- February 2020 (6)
- January 2020 (3)
- December 2019 (1)
